SOPHiA GENETICS raises €69.3M Series E round
3 January 2019· Rolle, Switzerland· health, ai, biotech, pure_software, b2b
The company plans to use the funds to grow its team, continue its expansion into the United States, and enable the more rapid adoption of Data-Driven Medicine technology in healthcare for the benefit of patients worldwide.
Investors
LeadGeneration Investment Management
Also participating
Idinvest Partners
About SOPHiA GENETICS
Stage
Bridge
Headquarters
Rolle, Switzerland
Founded
2011
Team Size
500+
Sectors
healthaibiotechpure_softwareb2b